Dr Dobri Kiprov Interview Series
Want to live longer? At some point, you will probably get TPE. Conboys is looking for funding to conduct human trials in order to develop a product within 3-4 years. We have information on the product, how it works and actual human results (starting 10 minutes).
In Part III Dr Kiprov discusses how the Conboy experiments were transformed into the clinical process and the reasons behind the decisions made. He also discusses the benefits he’s seen from plasma exchange in clinic.
Part I Video Link https://youtu.be/jpJlgSzRdyo.
Part II Video Link https://youtu.be/P0j96lU9_-g.
Dr Dobri Kiprov has been recognized internationally as a leader and pioneer in the field Therapeutic Apheresis. He is Chief of Division of Immunotherapy, California Pacific Medical Center San Francisco California and Medical director of Apheresis Care Group.
Dr Kiprov and Dr Conboy have been working together on plasma exchange for many years. They recently published a paper that reflects their experiences in the lab and clinic.
Dobri Kiprov M.D. (ASCP — Home Page.
https://dobrikiprov.com/
Here are some examples of papers by Dr Kiprov.
Blood products and therapeutic plasma exchange (TPE), implications for health and longevity.
https://pubmed.ncbi.nlm.nih.gov/34074614/
Repositioning plasmapheresis can reduce age-elevated factors in the blood: A new perspective and approach.
https://pubmed.ncbi.nlm.nih.gov/34083162/
AMBAR Study: Results of a randomized controlled trial of albumin replacement with plasma exchange for Alzheimer’s Disease.
https://pubmed.ncbi.nlm.nih.gov/32715623/
************************************************************
Health claims Disclaimer: The information provided in this video does not replace direct medical treatment or individual advice. Consult your doctor before using this video. This video does not recommend any products or services.
Source:
